Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acrocyanosis
advances in neurology
adverse drug reaction
algorithm
andexanet
anemia
angiography, cerebral
antiarrhythmic drugs
anticardiolipin antibodies
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation effect
anticoagulation, perioperative
antiphospholipid antibodies
antiphospholipid antibody syndrome
apixaban
arrhythmia, cardiac
aspirin
asymptomatic
atrial appendage closure
atrial cardiopathy
atrial fibrillation
atrial fibrillation, nonvalvular
atrial fibrillation, risk stratification
atrial fibrillation, surgical treatment
atrial fibrillation, treatment
atrial flutter
atrial septal defect
autoantibodies
autoimmune disease
bedridden
blindness
brain biopsy
breast feeding
bridge therapy
bronchoscopy
cancer associated hypercoagulation
cancer, cerebrovascular accident complicating patients with
carcinoma
cardiomyopathy
carotid angiogram
carotid artery occlusion, perioperative
CAT scan
CAT scan, abnormal
CAT scan, venography
cataract surgery
cerebral edema
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral veins
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, complications with
cerebrovascular accident, cryptogenic
cerebrovascular accident, nonarterial territory
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, young adult
CHADS2
children
ciraparantag
clopidogrel
clot retrieval
coagulopathy
colonoscopy
complications
congenital malformation
controversies in neurology
cortical vein thrombosis
cost
cost effectiveness
coumarin
coumarin, restarting treatment
coumarin, stopping treatment
craniectomy, decompressive
dabigatran
Dandy Walker malformation
deafness
deafness, congenital
deafness, unilateral
delay in diagnosis
delivery, complicated
dementia
dementia, cerebrovascular disease causing
dementia, presenile
dental extraction
dental procedure, neurologic complications with
developmental abnormality of brain
developmental retardation
drug interactions
dural sinus thrombosis
echocardiogram
echocardiogram, transesophageal
edoxaban
efficacy
electromyogram
embolic stroke of unknown source
embolism
embolism, systemic
endocarditis, marantic
endoscopic surgery
endoscopy
endovascular therapy
enoxaparin
evidence-based research
facial nerve palsy
factor Xa inhibitor
falling
false positive
false positive VDRL
fetal alcohol syndrome
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fontanel, bulging
gammaglobulin therapy, intravenous
gastrointestinal bleeding
gender
head injury
headache
headache, severe
headache, thunderclap
heart valve, prosthetic
hematoma, intracerebral
hemianopia, homonymous
hemorrhage, intracranial, newborn
hemorrhagic diathesis
hemostatic therapy
heparin
heparin, low-molecular-weight
heprain induced thrombocytopenia
heralding manifestation
hip arthroplasty
Holter monitoring
hormone replacement
hormone therapy
hydrocephalus
hypercoagulable state
hypertension
iatrogenic neurologic disorders
idarucizumab
incidental finding
inferior vena cava filter
INR value, time in range
INR values
intellectual deficit
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, silent
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure, increased
labor, complicated
left atrial appendage, percutaneous closure
left ventricular dysfunction
livedo reticularis
liver function enzymes
lumbar puncture, complications of
lupus anticoagulant
lymphoma
macrocephaly
malformation, CNS, congenital
mastoiditis
menopause
mental retardation
microangiopathy, brain
microcephaly
microhemorrhage, intracerebral
micropthalmia
mimics
misdiagnosis
mitral valve lesion
mitral valve prolapse
mortality
MRI
MRI, abnormal
MRI, venography
multiple organ failure
myocardial infarction
myotonia dystrophica
neurologic complications of, surgery
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic signs
NIH stroke scale
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
obstetric complications
occipital lobe, infarction
old age, neurology of
optic atrophy
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
otitis, neurologic complications with
ovarian induction
pacemaker, cardiac-transvenous
partial thromboplastin time
partial thromboplastin time, prolonged
patent foramen ovale
patent foramen ovale, percutaneous closure
patent foramen ovale, surgical treatment of
patient information and support
peripheral blood smear
peri-procedural
plasmapheresis
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, discontinuation
postoperative neurologic complications
postpartum
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
pulmonary embolism
radiofrequency ablation
Raynaud's phenomenon
recanalization, arterial
recurrent
Red flags
renal failure
renal infarct
renal vein thrombosis
reperfusion
RESPECT trial
review article
risk factors
risk stratification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
schistocytes
scoliosis
screening
seizure
seizure, focal
shunt procedure, ventricular
Sneddon's syndrome
solitaire device
steroid therapy, CNS treatment and complications with
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subdural hematoma
subdural hematoma, neonates and infants
superior sagittal sinus thrombosis
systemic illness
systemic lupus erythematosus
teratogenesis
teratogenic drugs
thrombectomy
thrombin inhibitor
thrombocytopenia
thrombolysis, mechanical
thrombophlebitis
thrombotic microangiopathy
thrombus, mural
tissue plasminogen activator, intravenous
transient ischemic attack
transient neurologic deficit
transluminal angioplasty, coronary artery
transurethral prostatectomy
treatment of neurologic disorder
Trousseau's syndrome
ultrasonography
vaccination, neurologic complications with
vaccine
valvulopathy
vasculopathy
venogram, cerebral
venous thrombosis, non-cerebral
visual field defect
vitamin K
vitamin K antagonist
Watchman device
white matter disease
workup
ximelagatran
Showing articles 50 to 100 of 2767 << Previous Next >>

Stability of International Normalized Ratios in Patients Taking Long-Term Warfarin Therapy
JAMA 316:661-662, Pokorney, S.D.,et al, 2016

Stroke Prevention in Atrial Fibrillation
JAMA 313:1950-1962, Lip, G.Y.H. & Lane, D.A., 2015

Peri-Procedural Management of Patients Taking Oral Anticoagulants
BMJ 351:h2391, Daniels, P.R., 2015

Risk of Gastrointestinal Bleeding Associated with Oral Anticoagulants: Population Based Retrospective Cohort Study
BMJ 350:h1585, h1679, Chang, H.Y.,et al, 2015

Comparative Risk of Gastrointestinal Bleeding with Dabigatran, Rivaroxaban, and Warfarin: Population Based Cohort Study
BMJ 350:h1857, h1979, Abraham, N.S.,et al, 2015

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015

Idarucizumab for Dabigatran Reversal
NEJM 373:511-520, Pollack, C.V.,et al, 2015

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
NEJM 373:2413-2424,2471, Siegal, D.M.,et al, 2015

Endovascular Treatment for Acute Ischemic Stroke in the Setting of Anticoagulation
Stroke 46:3536-3539, Rebello, L.C.,et al, 2015

FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
JAMA 314:2227, , 2015

Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014

Oral Anticoagulants and the Risk of Intracranial Hemorrhage
JAMA 312:2562-2563, Vespa, P.M., 2014

Summary of Evidence-Based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation
Neurol 82:716-724, Culebras, A.,et al, 2014

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials
Lancet 383:955-962,931, Ruff, C.T.,et al, 2014

Subdural Haematoma in the Elderly
BMJ 348:g1682, Teale, E.A.,et al, 2014

Rethinking Warfarin for Atrial Fibrillation
JAMA 311:1246, Zuccott, G & Pflomm, J.M., 2014

Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients with Atrial Fibrillation
JAMA 311:1150-1151, Bruins Slot, K.M.H. & Berge, E., 2014

Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis
Stroke 45:2469-2471, Geisbusch, C.,et al, 2014

Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated with Dabigatran or Warfarin
Stroke 45:2286-2291, Alonso, A.,et al, 2014

Cerebrovascular Events in 21 105 Patients with Atrial Fibrillation Randomized to Edoxaban Versus Warfarin
Stroke 45:2372-2378, Giugliano, R.P.,et al, 2014

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
Stroke 44:1676-1681, Harringotn, A.,et al, 2013

Summary of Evidence-Based Guideline: Periprocedural Management of Antithrombic Medications in Patients with Ischemic Cerebrovascular Disease
Neurol 80:2065-2069, Armstrong, M.,et al, 2013

Faxtor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 44:e165-e167, Bruins, K.M.H., & Berge, E., 2013

Edoxaban Versus Warfarin in Patients with Atrial Fibrillation
NEJM 369:2093-2104, Giugliano, R.P.,et al, 2013

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012

Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012

Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
Stroke 43:3442-3453, Furie, K.,et al, 2012

Bleeding During Treatment with Aspirin Versus Apixaban in Patients with Atrial Fibrillation Unsuitable for Warfarin
Stroke 43:3291-3297, Flaker, G.,et al, 2012

Nonvitamin K-Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
Stroke 43:3298-3304, Ntaios, G.,et al, 2012

Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012

Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011

Rivaroxaban versus Warfarin in Nonvavular Atrial Fibrillation
NEJM 365:883-891, 952, Patel, M.R.,et al, 2011

Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011

Dabigatran Etexilate versus Warfarin in Management of Non-Valvular Atrial Fibrillation in UK Context: Quantitative Benefit-Harm and Economic Analyses
BMJ 343:d6333, Pink, J.,et al, 2011

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010

Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007

Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006

Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Anticoagulation or Inferior Vena Cava Filter Placement for Patients with Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke 34:2999-3005, Kelly,J.,et al, 2003

Sneddon's Syndrome is a Thrombotic Vasculopathy:Neuropathologic and Neuroradiologic Evidence
Neurol 45:557-560, Geschwind,D.H.,et al, 1995

Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987

The Dandy-Walker Syndrome
In Handbk of Clin Neurology, Elsevier Publ, Amsterdam, 50:32387., Epstein,M.H.&Johanson,C.E., 1987

Maternal & Fetal Sequelae of Anticoagulation During Pregnancy
Am J Med 68:122-140, Hall,J.G.,et al, 1980

Cerebral Microbleeds
Stroke 52:2347-2355, Graff-Radford, J.,et al, 2021

Thigh Pain After a Stroke
BMJ 371:m3697, Long, V. & Tham, S.-L., 2020



Showing articles 50 to 100 of 2767 << Previous Next >>